SUBSCRIPTION AGREEMENT
Exhibit
10.6
SUBSCRIPTION
AGREEMENT (“Agreement”) made as of this _____ day of ___________, 2008, by and
among VeruTEK Technologies, Inc., a Nevada corporation (the “Company”), and the
undersigned subscriber of securities of the Company (the
“Subscriber”).
WHEREAS,
the Company intends to obtain subscriptions for the purchase and sale, in a
private placement transaction (the “Offering”) pursuant to Regulation D
promulgated under the Securities Act of 1933, as amended (the “Act”), of Units
(the “Units”) each consisting of two (2) shares of common stock of the
Company, par value $.001 per share (the “Common Stock”), and a warrant to
purchase one (1) share of Common Stock (a “Warrant”) at an exercise price of
$1.30 per share (the “Warrants” and the Common Stock issuable upon the exercise
of the Warrants are referred to herein as the “Warrant Shares”), on
the terms and conditions hereinafter set forth, and the Subscriber desires to
acquire that number of Units set forth on the signature page hereof. The Units,
the Common Stock, the Warrants and the Warrant Shares are sometimes individually
and collectively referred to herein as “Securities.”
NOW,
THEREFORE, for and in consideration of the promises and the mutual covenants
hereinafter set forth, the parties hereto do hereby agree as
follows:
1. Subscription
Procedure
1.1
|
Subject
to the terms and conditions hereinafter set forth, the Subscriber hereby
subscribes for and agrees to purchase from the Company such number of
Units as is set forth upon the signature page hereof at a price of $2.20
per Unit (the “Purchase Price”). Subject to the terms and
conditions hereinafter set forth, the Company agrees to sell such Units to
the Subscriber for the Purchase
Price.
|
1.2
|
The
subscription period will begin as of April 18, 2008, and will terminate at
5:00 PM Eastern Daylight Time on May 16, 2008, unless terminated earlier
or extended by the Company (the “Termination Date”). The
minimum dollar amount of Units that may be purchased by the Subscriber is
$25,000 unless the Company elects to waive the requirement. The
consummation of the subscription contemplated hereby, in whole or in part,
is subject to the satisfaction of the closing conditions set forth in
Section 5 of this Agreement.
|
1.3
|
The
Purchase Price will be held by Mintz, Levin, Cohn, Ferris, Glovsky and
Popeo, P.C., counsel to the Company, as escrow agent (“Mintz Xxxxx”), in a
non-interest bearing escrow account until the closing of the purchase of
the Units in the Offering pursuant to this Agreement (the “Subscription
Closing”). There may be multiple closings and amounts held in
escrow at the time of any closing may be released at such closing;
provided that the initial closing shall not occur until there are at least
$5,000,000 of subscriptions in the aggregate being held by Xxxxx Xxxxx
(the “Initial Closing”).
|
1.4
|
The
certificates for the Common Stock together with the accompanying Warrants
bearing the name of the Subscriber will be delivered by the Company no
later than twenty (20) business days following the final closing date of
the Offering. The Subscriber hereby authorizes and directs the
Company to deliver the securities to be issued to the Subscriber pursuant
to this Agreement to the residential or business address indicated in the
Investor Questionnaire (as defined
below).
|
1.5
|
A
copy of this Agreement, once executed by the Subscriber, should be faxed
to (and the original sent by overnight courier
to):
|
1
Xxxx
Xxxxxxx
Chief
Financial Officer
00 Xxxx
Xxxxxx Xxxx Xxxx, Xxxxx 000
Xxxxxxxxxx,
XX 00000
Fax: (000)
000-0000
1.6
|
The
Purchase Price for the Units purchased hereunder shall be paid by
certified check, payable to Xxxxx Xxxxx, Cohn, Ferris, Glovsky and Popeo,
P.C, or by wire transfer to the Mintz Xxxxx client funds account pursuant
to the following instructions:
|
All
wire transfers should also be accompanied by a facsimile notification of the
wire to the attention of Xxxx Xxxxxxx at (000) 000-0000.
1.7 The
Company may, in its sole discretion, reject any subscription, in whole or in
part, or terminate or withdraw the Offering in its entirety at any time prior to
a closing in relation thereto. The Company shall not be required to
allocate among investors on a pro rata basis in the event of an
over-subscription.
2. Representations and
Covenants of Subscriber.
2.1
|
The
Subscriber recognizes that the purchase of Units involves a high degree of
risk in that (i) the Company will need additional capital but has no
assurance of additional necessary capital; (ii) an investment in the
Company is highly speculative and only investors who can afford the loss
of their entire investment should consider investing in the Company and
the Units; (iii) an investor may not be able to liquidate his or her
investment; (iv) transferability of the securities comprising the
Units is extremely limited; (v) an investor could sustain the loss of
his or her entire investment; and (vi) the Company is and will be
subject to numerous other risks and uncertainties, including without
limitation, significant and material risks relating to the Company’s
business, and the industries and markets in which the Company will
compete, as well as risks associated with the Offering, and the other
transactions contemplated herein, in the Offering Memorandum dated
February 16, 2008 and any supplements thereto (including all exhibits,
schedules and attachments thereto, the “Offering Memorandum”), all as more
fully set forth herein and in the Offering
Memorandum.
|
2.2
|
The
Subscriber represents that he or she is an “accredited investor” as such
term is defined in Rule 501 of Regulation D promulgated under the Act, as
indicated by his or her responses to the Investor Questionnaire (the
“Investor Questionnaire”), the form of which is attached hereto as Exhibit A,
and that he or she is able to bear the economic risk of an investment in
the Units. The Subscriber must complete the Investor
Questionnaire to enable the Company to assess the Subscriber’s eligibility
for the Offering.
|
2.3
|
The
Subscriber acknowledges that he or she has prior investment experience,
including without limitation, investment in non-listed and non-registered
securities, and he or she has read all of the documents furnished or made
available by the Company to him or her and evaluated the merits and risks
of such an investment, and that he or she recognizes the highly
speculative nature of this
investment.
|
2
2.4
|
The
Subscriber acknowledges receipt and careful review of the Offering
Memorandum, this Agreement, the Common Stock Purchase Warrant representing
the Warrants and any other attachments hereto and thereto (collectively,
the “Offering Documents”) and hereby represents that he or she has been
furnished or given access by the Company during the course of this
Offering with or to all information regarding the Company and its
respective financial condition and results of operations which he or she
had requested or desired to know; that all documents which were
specifically requested by the Subscriber and could be reasonably provided
have been made available for his or her inspection and review; that he or
she has been afforded the opportunity to ask questions of and receive
answers from duly authorized representatives of the Company concerning the
terms and conditions of the Offering, and any additional information which
he or she had requested. The Subscriber further represents and
acknowledges that the Subscriber has not seen or received any
advertisement or general solicitation with respect to the sale of any of
the securities of the Company, including, without limitation, the
Units.
|
2.5
|
The
Subscriber acknowledges that this Offering of Units may involve tax
consequences, and that the contents of the Offering Documents do not
contain tax advice or information. The Subscriber acknowledges
that he or she must retain his or her own professional advisors to
evaluate the tax and other consequences of an investment in the
Units.
|
2.6
|
The
Subscriber acknowledges that this Offering of Units has not been reviewed
or approved by the United States Securities and Exchange Commission
(“SEC”) and that the Offering is intended to be a nonpublic offering
pursuant to Section 4(2) of the Act. The Subscriber represents
that the Units are being purchased for his or her own account, for
investment and not for distribution or resale to others. The
Subscriber agrees that he or she will not sell or otherwise transfer any
of the securities comprising the Units unless they are registered under
the Act and any applicable state “blue sky” securities laws or unless an
exemption from such registration is available and, upon the Company’s
request, the Company receives an opinion of counsel reasonably
satisfactory, in all respects, to the Company confirming that an exemption
from such registration is available for such sale or
transfer.
|
2.7
|
The
Subscriber understands that the Units have not been registered under the
Act by reason of a claimed exemption under the provisions of the Act which
depends, in part, upon his or her investment intention. The
Subscriber realizes that, in the view of the SEC, a purchase now with the
intention to distribute would represent a purchase with an intention
inconsistent with his or her representation to the Company, and the SEC
might regard such a distribution as a deferred sale to which such
exemption is not available.
|
2.8
|
The
Subscriber understands that Rule 144 (the “Rule”) promulgated under the
Act requires, among other conditions, a holding period prior to the resale
of securities acquired in a non-public offering, such as the Offering,
without having to satisfy the registration requirements under the
Act. The Subscriber consents that the Company may, in its sole
discretion and if it desires, permit the transfer of the Common Stock
included in the Units or issuable upon the exercise of the Warrants, in
whole or in part, out of his or her name but only when his or her request
for transfer is accompanied by an opinion of counsel reasonably
satisfactory to the Company, in all respects, that neither the sale nor
the proposed transfer results in a violation of the Act, any applicable
state “blue sky” securities laws or any applicable securities laws of any
other country, province or jurisdiction (collectively, “Securities
Laws”). The Subscriber agrees to hold the Company and its
respective directors, officers and controlling persons and their
respective heirs, representatives, successors and assigns harmless and to
indemnify them against all liabilities, costs and expenses incurred by any
of them as a result of any misrepresentation made by him or her contained
herein or in the Investor
Questionnaire.
|
2.9
|
The
Subscriber consents to the placement of one or more legends on any
certificate or other document evidencing his or her Units and the Common
Stock or Warrants included in the Units or issuable upon the exercise of
the Warrants stating that they have not been registered under the Act and
are subject to the terms of this Agreement, and setting forth or referring
to the restrictions on the transferability and sale
thereof.
|
3
2.10
|
The
Subscriber understands and acknowledges that the Company will review this
Agreement and the Investor Questionnaire and the Company reserves the
unrestricted right, in its sole discretion, to reject or limit any
subscription and to close the Offering at any time or not close the
Offering.
|
2.11
|
The
Subscriber hereby represents that the address of Subscriber furnished at
the end of this Agreement and in the Investor Questionnaire is the
undersigned's principal residence if he or she is an individual or its
principal business address if it is a corporation or other
entity.
|
2.12
|
The
Subscriber acknowledges that if the Subscriber is a Registered
Representative of a the Financial Industry Regulatory Authority (“FINRA”)
member firm, he or she must give such firm the notice required by the
FINRA Conduct Rules, or any applicable successor rules of FINRA, receipt
of which has been acknowledged by such firm on the signature page
hereof. The Subscriber shall also notify the Company if the
Subscriber or any affiliate of Subscriber is a registered broker-dealer,
in which case the Subscriber represents that the Subscriber is purchasing
the Units in the ordinary course of business and, at the time of purchase
of the Units, has no agreements or understandings, directly or indirectly,
with any person to distribute the Units or any portion
thereof.
|
2.13
|
The
Subscriber hereby represents that, except as set forth in the Offering
Documents, no representations or warranties have been made to the
Subscriber by the Company or its agents, employees or affiliates and in
entering into this transaction, the Subscriber is not relying on any
information, other than that contained in the Offering
Documents.
|
2.14
|
The
Subscriber agrees that he or she will purchase securities in the Offering
only if his or her intent at such time is to make such purchase for
investment purposes and not with a view toward
resale.
|
2.15
|
If
the undersigned Subscriber is a partnership, corporation, trust or other
entity, such partnership, corporation, trust or other entity further
represents and warrants that: (i) it was not formed for
the purpose of investing in the Company; (ii) it is authorized and
otherwise duly qualified to purchase and hold the Units; and
(iii) that this Agreement has been duly and validly authorized,
executed and delivered and constitutes the legal, binding and enforceable
obligation of the undersigned.
|
2.16
|
If
the Subscriber is not a United States person, such Subscriber hereby
represents that it has satisfied itself as to the full observance of the
laws of its jurisdiction in connection with any invitation to subscribe
for the Units or any use of this Agreement, including (i) the legal
requirements within its jurisdiction for the purchase of the Units, (ii)
any foreign exchange restrictions applicable to such purchase, (iii) any
governmental or other consents that may need to be obtained, and (iv) the
income tax and other tax consequences, if any, that may be relevant to the
purchase, holding, redemption, sale or transfer of the
Units. Such Subscriber's subscription and payment for, and his
or her or her continued beneficial ownership of the Units and of the
shares of Common Stock included therein or to be issued upon the exercise
of the Warrants, will not violate any applicable securities or other laws
of the Subscriber's jurisdiction.
|
4
2.17
|
The
Subscriber acknowledges that (i) the Offering Memorandum may contain
material, non-public information concerning the Company within the meaning
of Regulation FD promulgated by the SEC, and (ii) the Subscriber is
obtaining such material, non-public information solely for the purpose of
considering whether to purchase the Units pursuant to a private placement
that is exempt from registration under the Act. In accordance
with Regulation FD and other applicable provisions of the Securities Laws,
the Subscriber agrees to use such information only for the purpose set
forth above in the immediately preceding sentence and to keep such
information confidential and not to disclose it to any other person or
entity except the Subscriber’s legal counsel, other advisors and other
representatives who have agreed (i) to keep such information
confidential, (ii) to use such information only for the purpose set
forth above, and (iii) to comply with applicable securities laws with
respect to such information. In addition, the Subscriber
further acknowledges that the Subscriber and such legal counsel, other
advisors and other representatives are prohibited from trading in the
Company’s securities while in possession of material, non-public
information and agrees to refrain from purchasing or selling securities of
the Company until such material, non-public information has been publicly
disseminated by the Company.
|
2.18
|
The
Subscriber understands and acknowledges that (i) the Units are being
offered and sold to Subscriber without registration under the Act in a
private placement that is exempt from the registration provisions of the
Act under Section 4(2) of the Act and (ii) the availability of such
exemption depends in part on, and that the Company will rely upon the
accuracy and truthfulness of, the foregoing representations, and such
Subscriber hereby consents to such
reliance.
|
2.19
|
Neither
the Subscriber, nor any Person acting on behalf of or pursuant to any
understanding with the Subscriber, has, directly or indirectly, engaged in
any transaction in the securities of the Company (including, without
limitation any Short Sales involving any of the Company’s securities)
since the time that such Subscriber was first contacted by the Company, or
any other Person regarding an investment in the Company. Such
Subscriber covenants that neither it nor any Person acting on its behalf
or pursuant to any understanding with such Subscriber will engage,
directly or indirectly, in any transaction in the securities of the
Company (including Short Sales) prior to the time the transaction
contemplated by this Agreement are publicly disclosed or while the
Subscriber is in possession of any material non-pubic
information. “Short Sales” include, without limitation, all
“short sales” as defined in Rule 200 promulgated under Regulation SHO
under the Exchange Act (as defined below) and all types of direct and
indirect stock pledges, forward sale contracts, options, puts, calls,
short sales, swaps, derivatives and similar arrangements (including on a
total return basis), and sales and other transactions through non-U.S.
broker-dealers or foreign regulated
brokers.
|
3. Representations by the
Company
Except as
set forth in the reports previously filed by the Company on or after
May 15, 2007 (the “SEC Reports”) pursuant to the Securities Exchange Act of
1934, as amended (the “Exchange Act”), or in the Offering Memorandum, the
Company represents and warrants to the Subscriber that:
3.1
|
Organization and
Authority. The Company, and each of its respective
subsidiaries, if any (i) is a corporation validly existing and in
good standing under the laws of the jurisdiction of its incorporation, and
(ii) has all requisite corporate power and authority to own, lease
and operate its properties and to carry on its business as presently
conducted, and the Company has all requisite corporate power and authority
to execute, deliver and perform its obligations under this Agreement and
the Offering Documents being executed and delivered by it in connection
herewith, and to consummate the transactions contemplated hereby and
thereby.
|
3.2
|
Qualifications. The
Company, and each of its respective subsidiaries, if any, is duly
qualified to do business as a foreign corporation and is in good standing
in all jurisdictions where such qualification is necessary and where
failure to so qualify could have a material adverse effect on the
business, properties, operations, condition (financial or other), results
of operations or prospects of the Company and its subsidiaries, taken as a
whole or has the affect of preventing the Company from performing any of
its duties or obligations under this Agreement (a “Material Adverse
Effect”).
|
3.3
|
Capitalization of the
Company. The Common Stock and the Warrants to be issued
to the Subscriber have been duly authorized, and when issued and paid for
in accordance with this Agreement, the Common Stock will be duly and
validly issued, fully paid and non-assessable, and the Warrant Shares,
when issued upon exercise of the Warrants in exchange for the payment in
full of the exercise price for such Warrant Share therein specified, will
be duly and validly issued, fully paid and
non-assessable.
|
5
3.4
|
Corporate
Authorization. The Offering Documents have been duly and
validly authorized by the Company. This Agreement, assuming due execution
and delivery by the Subscriber, and the Warrants, when the Subscription
Agreement and the Warrants are executed and delivered by the Company, will
be, valid and binding obligations of the Company, enforceable in
accordance with their respective terms, except as the enforceability
hereof and thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws now or hereafter in
effect relating to or affecting creditors’ rights generally and general
principles of equity, regardless of whether enforcement is considered in a
proceeding in equity or at law.
|
3.5
|
Non-Contravention. The
execution and delivery of the Offering Documents by the Company, the
issuance of the Units as contemplated by the Offering Documents, with or
without the giving of notice or the lapse of time, or both, will not (i)
result in any violation of any provision of the articles of incorporation
or by-laws or similar instruments of the Company or its respective
subsidiaries, if any, (ii) conflict with or result in a breach by the
Company or its respective subsidiaries of any of the terms or provisions
of, or constitute a default under, or result in the modification of, or
result in the creation or imposition of any lien, security interest,
charge or encumbrance upon any of the properties or assets of the Company
or its respective subsidiaries (if any) pursuant to, any agreements,
instruments or documents filed as exhibits to the SEC Reports or any
indenture, mortgage, deed of trust or other agreement or instrument to
which Company or any of its subsidiaries is a party or by which Company or
any of its subsidiaries or any of its properties or assets are bound, in
any such case which would have a Material Adverse Effect, except to the
extent that such conflict, breach, default, modification, lien, security
interest, charge or encumbrance has been consented to or approved by or on
behalf of the other party or parties to such agreement, instrument,
document, indenture, mortgage, deed of trust or other agreement or
instrument prior to the consummation of the Offering, (iii) violate or
contravene any applicable law, rule or regulation or any applicable
decree, judgment or order of any court, United States federal or state
regulatory body, administrative agency or other governmental body having
jurisdiction over Company or any of its subsidiaries or any of its
respective properties or assets that would have a Material Adverse Effect,
(iv) have any material adverse effect on any permit, certification,
registration, approval, consent, license or franchise necessary for the
Company or its subsidiaries to own or lease and operate any of its
properties and to conduct any of its business or the ability of the
Company or its subsidiaries to make use thereof or (v) except for
applicable requirements of federal securities laws and state securities or
blue-sky laws, require filing with, or permit, authorization, consent or
approval of, any third party, public body or authority, other than any
filing, permit, authorization, consent or approval made or obtained prior
to the consummation of the Offering, except those which the failure to so
make or obtain would not have a Material Adverse
Effect.
|
3.6
|
Information
Provided. The Company hereby represents and warrants to
the Subscriber that the information set forth in the Offering Memorandum,
the SEC Reports and any other document provided by the Company (or the
Company’s authorized representatives) to the Subscriber in connection with
the transactions contemplated by this Agreement, did not (in each case as
of the respective date thereof) contain any untrue statement of a material
fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which they are
made, not misleading.
|
3.7
|
Events
Subsequent. Since January 1, 2008, as to the
Company, there has not been any of the following that have not been
disclosed to the Subscriber or disclosed in the SEC
Reports:
|
(a) Any
sale, lease, transfer, license or assignment of any assets, tangible or
intangible, of the Company, other than in the ordinary course of
business;
(b) Any
material damage, destruction or property loss, whether or not covered by
insurance, affecting adversely the properties or business of the
Company;
6
(c) Any
declaration or setting aside or payment of any dividend or distribution with
respect to the shares of capital stock of the Company or any redemption,
purchase or other acquisition of any such shares;
(d) Any
subjection to any material lien on any of the assets, tangible or intangible, of
the Company, other than in the ordinary course of business;
(e) Any
incurrence of any material indebtedness by the Company;
(f) Any
waiver or release by the Company of any right of any material
value;
(g) Any
material increase in compensation or benefits paid to officers or directors of
the Company, other than in the ordinary course of business;
(h) Any
material change made or authorized in the articles of incorporation or bylaws of
the Company, except in the ordinary course of business;
(i) Any
loan to or other transaction with any officer, director or stockholder of the
Company giving rise to any material claim or right of the Company against any
such person or of such person against the Company; or
(j) Any
material adverse change in the condition (financial or otherwise) of the
respective properties, assets, liabilities or business of the Company;
or
(k) any
agreement, written or otherwise, to take any of the foregoing
actions.
3.8
|
Compliance with
Law. Neither the Company nor any of its respective
subsidiaries is in violation of or has any liability under any statute,
law, rule, regulation, ordinance, decision or order of any governmental
agency or body or any court, domestic or foreign, except where such
violation or liability would not individually or in the aggregate have a
Material Adverse Effect and to the knowledge of the Company there is no
pending investigation that would reasonably be expected to lead to such a
claim.
|
3.9
|
Consents. The
Company has all necessary consents, approvals, authorizations, orders,
registrations, qualifications, licenses, filings and permits of, with and
from all applicable judicial, regulatory and other legal or governmental
agencies and bodies and all third parties, foreign and domestic
(collectively, the “Consents”), to own, lease and operate their respective
properties and conduct their respective businesses as are now being
conducted and as disclosed in the Offering Memorandum, except where the
failure to have any such Consent would not have a Material Adverse
Effect. Each such Consent is valid and in full force and
effect, and the Company has not received written notice of any
investigation or proceedings which results in or, if decided adversely to
the Company, could reasonably be expected to result in, the revocation of,
or imposition of a materially burdensome restriction on, any
Consent.
|
3.10
|
Questionable
Payments. Neither the Company, nor any of its respective
employees, agents or representatives have, directly or indirectly, made
any bribes, kickbacks, illegal payments or illegal political contributions
using Company funds or made any payments from the Company's funds,
respectively, to governmental officials for improper purposes or made any
illegal payments from the Company's funds, respectively, to obtain or
retain business.
|
7
3.11
|
Intellectual
Property. The Company does not have any knowledge of any
claim that, or inquiry as to whether, any product or service of the
Company infringes upon or involves, or has resulted in the infringement
of, any trademarks, patents, copyrights or other proprietary rights of any
other person, corporation or other entity; and no such proceedings have
been instituted, are pending or, to the Company’s knowledge, are
threatened against the Company. The Company: (i) owns or
possesses all rights to use and/or license, as the case may be, all
material patents, including any associated patent applications,
trademarks, including any service marks, trade names, or registrations or
applications therefor, copyrights and other intellectual property
(including trade secrets and other unpatented and/or unpatentable
proprietary or confidential information, systems, formulae or procedures,
“Intellectual Property”) necessary for the conduct of its business as
being conducted and as described in the Offering Memorandum except where
the failure to so own or possess would not have a Material Adverse Effect
and (ii) does not believe that the conduct of its business
does or will conflict with, and has not received any notice of any claim
of conflict with, any such right of others, which conflict would have a
Material Adverse Effect. All Intellectual Property developed by
and belonging to Company (including, without limitation, that which is
developed by contractors to Company which has not been patented) has been
kept confidential using reasonable commercial efforts. To
Company’s knowledge, there is no infringement by third parties of any
Intellectual Property owned by the Company. There are no
pending or, to Company’s knowledge, threatened actions, suits, proceedings
or claims by others challenging Company’s rights in or to any Intellectual
Property.
|
3.12
|
Insurance. Company
maintains insurance in such amounts and covering such risks as are
customary for similarly-sized companies engaged in similar businesses in
similar industries, all of which insurance is in full force and
effect. There are no material claims by Company under any such
policy or instrument as to which any insurance company is denying
liability or defending under a reservation of rights
clause. Company reasonably believes that it will be able to
renew its existing insurance as and when such coverage expires or will be
able to obtain replacement insurance adequate for the conduct of its
business.
|
3.13
|
Legal
Compliance. To the knowledge of the Company, no claim
has been filed against the Company alleging a violation of any applicable
laws or regulations of foreign, federal, state and local governments and
all agencies thereof. The Company holds all of the material
permits, licenses, certificates or other authorizations of foreign,
federal, state or local governmental agencies required for its respective
business as presently conducted.
|
3.14
|
Listing and
Maintenance Requirements. The Company’s common stock is
currently quoted on the OTC Bulletin Board. The Company has
not, since May 15, 2007, received any notice from the OTC Bulletin
Board or FINRA or any trading market on which the Company’s common stock
is or has been listed or quoted to the effect that the Company is not in
compliance with the quoting, listing or maintenance requirements of the
OTC Bulletin Board or such other trading market. The Company is
in compliance with all such quoting, listing and maintenance requirements
in all material respects.
|
3.15
|
No SEC or FINRA
Inquiries. Neither the Company nor, to the Company’s
knowledge, any of its past or present officers or directors is the subject
of any formal or informal inquiry or investigation by the SEC or
FINRA.
|
3.16
|
Disclosure. The
representations and warranties and statements of fact made by the Company
in this Agreement are, as applicable, accurate, correct and complete and
do not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements and
information contained herein not false or misleading. The
Company is and, at all times up to and including consummation of the
transactions contemplated by this Agreement, and after giving effect to
application of the net proceeds of the Placement, will not be, subject to
registration as an “investment company” under the Investment Company Act
of 1940, as amended (the “1940 Act”), and is not and will not be an entity
“controlled” by an “investment company” within the meaning of the 1940
Act. The Company will initially utilize the proceeds of the
Offering in such a manner so as to cause Company not to be subject to the
1940 Act, and will thereafter use its commercially reasonable efforts to
avoid Company becoming subject to the 0000
Xxx.
|
3.17
|
Anti-takeover Device. Neither the Company nor any of its respective subsidiaries has any outstanding shareholder rights plan or “poison pill” or any similar arrangement. There are no provisions of any anti-takeover or business combination statute applicable to the Company or its Articles of Incorporation or Bylaws which would preclude the issuance and sale of the Securities, the reservation for issuance of the Warrant Shares and the consummation by the Company of the other transactions contemplated by this Agreement or any of the other Offering Documents. |
8
3.18
|
Securities Law Compliance. Subject to the accuracy and completeness of the representations and warranties of the Subscriber contained in this Agreement, the Company has complied and will comply with all applicable federal and state securities laws in connection with the offer, issuance and sale of the Securities hereunder. Neither the Company nor anyone acting on its behalf, directly or indirectly, will sell, offer to sell or solicit offers to buy any of the Securities or similar securities to, or solicit offers with respect thereto from, or enter into any negotiations relating thereto with, any person, or has taken or will take any action, in any such case so as to bring the issuance and sale of any of the Securities issuable in the Offering under the registration provisions of the Act and applicable state securities laws, and neither the Company nor, to the knowledge of the Company, any of its affiliates or any person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Act) in connection with the offer or sale of any of the Securities |
4. Covnants
The
Company covenants with the Subscriber as follows, which covenants are for the
benefit of the Subscriber and its, his or her permitted assignees.
4.1 Securities
Compliance. The Company shall notify the SEC in accordance
with its rules and regulations, of the transactions contemplated by any of
Offering Documents and shall take all other necessary action and proceedings as
may be required and permitted by applicable law, rule and regulation, for the
legal and valid issuance of the Securities to the Subscriber, or their
respective subsequent holders.
4.2 Reporting
Requirements. If the Company ceases to file its periodic
reports with the SEC, or if the SEC ceases making these periodic reports
available via the Internet without charge, then the Company shall, promptly
after filing with the SEC, furnish the following to the Subscriber so long as
the Subscriber shall be obligated hereunder to purchase the Securities or shall
beneficially own Securities:
(a) Quarterly
Reports filed with the SEC on Form 10-Q, if any;
(b) Annual
Reports filed with the SEC on Form 10-K, if any; and
|
(c)
|
Copies
of all notices, information and proxy statements in connection with any
meetings, that are, in each case, provided to holders of shares of Common
Stock, if any, contemporaneously with the delivery of such notices or
information to such holders of Common
Stock.
|
4.3 Other
Agreements. The Company shall not enter into any agreement in
which the terms of such agreement would restrict or impair the right or ability
of the Company or any Subsidiary to perform in any material respect its
obligations under any Offering Documents.
4.4 Use of
Proceeds. The Company will use the net proceeds from the sale
of the Securities for the purposes set forth in the Offering Memorandum under
the section titled “Use of Proceeds.”
4.5 Form
D. The Company agrees to file a Form D with respect to the
Securities as required by Rule 506 under Regulation D.
4.6 No Integrated
Offerings. The Company shall not make any offers or sales of
any security (other than the Securities being offered or sold hereunder) under
circumstances that would require registration of the Securities being offered or
sold hereunder under the Act.
9
4.7 Pledge of
Securities. The Company acknowledges and agrees that the
Securities may be pledged by the Subscriber in connection with a bona fide loan or
financing arrangement that is secured by the Common Stock. The pledge
of Common Stock shall not be deemed to be a transfer, sale or assignment of the
Common Stock hereunder, and no Subscriber effecting a pledge of Common Stock
shall be required to provide the Company with any notice thereof or otherwise
make any delivery to the Company pursuant to this Agreement or the Warrants;
provided that the Subscriber and its pledgee shall be required to comply with
all of the provisions of this Agreement in order to effect a sale, transfer or
assignment of Common Stock to such pledgee. At the Subscriber's
expense, the Company hereby agrees to execute and deliver such documentation as
a pledgee of the Common Stock may reasonably request in connection with a pledge
of the Common Stock to such pledgee by the Subscriber.
4.8 Confidentiality. The
Subscriber agrees that it will not disclose and it will cause its officers,
directors, employees, representatives, agents, and advisers not to disclose, any
Confidential Information (as hereinafter defined), at any time or in any manner,
provided that (i) any disclosure of such information may be made to which
the Company and Subscriber consent in writing; and (ii) such information may be
disclosed if so, and to the extent, required by law or regulatory authority;
provided, however, that prior to disclosure of information pursuant to
clause (ii) above, Subscriber shall notify the Company that Subscriber
intends to make such disclosure and, upon the Company’s request, Subscriber use
all requisite reasonable efforts to obtain assurances that confidential
treatment will be accorded to such information to the extent such assurances are
available. “Confidential
Information” means information or knowledge obtained in any due diligence
or other investigation relating to the negotiation and execution of this
Agreement, information relating to the terms of the transactions contemplated
hereby and any information furnished by or on behalf of the Company or
identified as confidential in writing by the Company; provided, however, that
Confidential Information shall not include information or knowledge that
(a) becomes generally available to the public absent any breach of this
Section 4.10, (b) was available on a non-confidential basis to a party
prior to its disclosure pursuant to this Agreement, or (c) becomes
available on a non-confidential basis from a third party who is not bound to
keep such information confidential.
5. Closing
Conditions
5.1 Conditions Precedent to the
Obligation of the Company to Close and to Sell the
Securities. The obligation hereunder of the Company to close
and issue and sell the Securities to the Subscriber at the date of the
Subscription Closing (the “Subscription Closing Date”) is subject to the
satisfaction or waiver, at or before the Subscription Closing of the conditions
set forth below. These conditions are for the Company's sole benefit
and may be waived by the Company at any time in its sole
discretion.
(a) Accuracy of the Subscriber’s
Representations and Warranties. The representations and
warranties of the Subscriber shall be true and correct in all respects as of the
date when made and as of the Subscription Closing Date as though made at that
time, except for representations and warranties that are expressly made as of a
particular date, which shall be true and correct in all respects as of such
date.
(b) Performance by the
Subscriber. The Subscriber shall have performed, satisfied and
complied in all material respects with all covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the
Subscriber at or prior to the Subscription Closing Date.
10
(c) No
Injunction. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which
prohibits the consummation of any of the transactions contemplated by this
Agreement.
(d) No Proceedings or
Litigation. No action, suit or proceeding before any
arbitrator or any governmental authority shall have been commenced, and no
investigation by any governmental authority shall have been threatened, against
the Company or any Subsidiary, or any of the officers, directors or affiliates
of the Company or any Subsidiary seeking to restrain, prevent or change the
transactions contemplated by this Agreement, or seeking damages in connection
with such transactions.
(e) Delivery of Purchase
Price. The Subscriber shall have delivered to the Company the
purchase price for the Securities to be purchased by the
Subscriber.
(f) Delivery of this Agreement
and the Warrants. This Agreement and the Warrants shall have
been duly executed and delivered by the Subscriber.
(g) Acceptance of
Subscription. The subscription contemplated by this Agreement
shall have been accepted by the Company, in its sole discretion.
5.2 Conditions Precedent to the
Obligation of the Subscriber to Close and to Purchase the
Securities. The obligation hereunder of the Subscriber to
purchase the Securities and consummate the transactions contemplated by this
Agreement is subject to the satisfaction or waiver, at or before the
Subscription Closing Date, of each of the conditions set forth
below. These conditions are for the Subscriber’s sole benefit and may
be waived by the Subscriber at any time in its sole discretion.
(a) Delivery of Company
Certificate. The Company shall have delivered a certificate to
Xxxxx Xxxxx, as escrow agent, certifying as to the following:
(i) Accuracy of the Company's
Representations and Warranties. Each of the representations
and warranties of the Company in this Agreement is true and correct in all
respects as of the Subscription Closing Date, except for representations and
warranties that speak as of a particular date, which shall be true and correct
in all respects as of such date.
(ii) Performance by the
Company. The Company has performed, satisfied and complied in
all material respects with all covenants, agreements and conditions required by
this Agreement to be performed, satisfied or complied with by the Company at or
prior to the Subscription Closing Date.
(iii) No Suspension,
Etc. Trading in the Common Stock has not been suspended by the
SEC or the OTC Bulletin Board (except for any suspension of trading of limited
duration agreed to by the Company, which suspension shall be terminated prior to
the Subscription Closing Date), and, at any time prior to the Subscription
Closing Date, trading in securities generally as reported by Bloomberg Financial
Markets (“Bloomberg”) shall not
have been suspended or limited, or minimum prices shall not have been
established on securities whose trades are reported by Bloomberg, or on the New
York Stock Exchange, nor shall a banking moratorium have been declared either by
the United States or New York State authorities.
(iv) No
Injunction. No statute, rule, regulation, executive order,
decree, ruling or injunction has been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this
Agreement.
11
(v) No Proceedings or
Litigation. No action, suit or proceeding before any
arbitrator or any governmental authority has been commenced, and no
investigation by any governmental authority has been threatened, against the
Company or any Subsidiary, or any of the officers, directors or affiliates of
the Company or any Subsidiary seeking to restrain, prevent or change the
transactions contemplated by this Agreement, or seeking damages in connection
with such transactions.
(vi) Material Adverse
Effect. No Material Adverse Effect has occurred and is
continuing between the date of this Agreement and the Subscription
Closing Date.
(b) Receipt of Minimum
Subscriptions. For purposes of the Initial Closing, the escrow
agent shall have received at least an aggregate of $5,000,000 of subscription
funds, it being understood that such threshold amount and the satisfaction of
this Section 5.2(b) is not required for any subsequent closings
6. Miscellaneous.
6.1 Any
notice or other communication given hereunder shall be deemed sufficient if in
writing and sent by registered or certified mail, return receipt requested,
addressed to the Company at VeruTEK Technologies, Inc., 00 Xxxx Xxxxxx Xxxx
Xxxx, Xxxxx 000, Xxxxxxxxxx, XX 00000, Attention: Xxxx
Xxxxxxx, Chief Executive Officer, with a copy to (which shall not constitute
notice) Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Xxx Xxxxxxxxx
Xxxxxx, Xxxxxx, XX 00000, Attention: Sahir C. Surmeli, Esq., and to
the Subscriber at the address indicated on the signature page of this
Agreement. Notices shall be deemed to have been given three (3)
business days after the date of mailing, except notices of change of address,
which shall be deemed to have been given when received.
6.2 This
Agreement may be amended through a written instrument signed by the Subscriber
and the Company; provided, however, that the terms of Section 4 of this
Agreement may be amended without the consent or approval of the Subscriber so
long as such amendment applies in the same fashion to the subscription
agreements of all of the other subscribers for Units in the Offering and the
other terms of this Agreement may be amended without the consent or approval of
the Subscriber so long as such amendment applies in the same fashion to the
subscription agreements of all of the other subscribers for Units in the
Offering and at least holders of a majority of the Units sold in the Offering
have given their approval of such amendment, which approval shall be binding on
all holders of Units.
6.3 This
Agreement shall be binding upon and inure to the benefit of the parties hereto
and to their respective heirs, legal representatives, successors and
assigns. This Agreement sets forth the entire agreement and
understanding between the parties as to the subject matter hereof and merges and
supersedes all prior discussions, agreements and understandings of any and every
nature among them. This Agreement may not be assigned by the
Subscriber without the prior written consent of the Company.
6.4 Notwithstanding
the place where this Agreement may be executed by any of the parties hereto, the
parties expressly agree that all the terms and provisions hereof shall be
construed in accordance with and governed by the laws of the State of Nevada
(without regard to the choice of law rules thereof).
6.5 This
Agreement may be executed in counterparts. Notwithstanding anything
in herein to the contrary, this Agreement shall not be binding upon the Company
unless and until it is accepted by the Company. Upon the execution
and delivery of this Agreement by the Subscriber, this Agreement shall become a
binding obligation of the Subscriber with respect to the purchase of Units as
herein provided; subject, however, to the right hereby reserved to the Company
to enter into the same agreements with other subscribers and to add and/or to
delete other persons as subscribers.
12
6.6 The
holding of any provision of this Agreement to be invalid or unenforceable by a
court of competent jurisdiction shall not affect any other provision of this
Agreement, which shall remain in full force and effect.
6.7 It
is agreed that a waiver by either party of a breach of any provision of this
Agreement shall not operate, or be construed, as a waiver of any subsequent
breach by that same party.
6.8 The
parties agree to execute and deliver all such further documents, agreements and
instruments and take such other and further action as may be necessary or
appropriate to carry out the purposes and intent of this Agreement.
6.9 The
Company and the Subscriber acknowledge and agree that irreparable damage would
occur in the event that any of the provisions of this Agreement or the other
Offering Documents are not performed in accordance with their specific terms or
are otherwise breached. It is accordingly agreed that the parties
shall be entitled to an injunction or injunctions to prevent or cure breaches of
the provisions of this Agreement or the other Offering Documents and to enforce
specifically the terms and provisions hereof or thereof, this being in addition
to any other remedy to which any of them may be entitled by law or
equity.
6.10 The
representations and warranties of the Company and the Subscriber shall survive
the execution and delivery hereof and the Subscription Closing until the second
anniversary of the Subscription Closing Date.
6.11 As
the context requires, all terms used herein in the singular shall extend to and
include the plural, all terms used in the plural shall extend to and include the
singular, and all terms used in either gender or the neuter shall extend to the
other gender or be neutral. All pronouns contained herein, and any
variations thereof, shall be deemed to refer to the masculine, feminine or
neutral, singular or plural, as the identity of the parties hereto may
require. For purposes of this Agreement, the words “knowledge of the
Company,” “Company’s knowledge” and similar language shall mean the actual
knowledge of the executive officers of the Company.
6.12 The
obligation of the Subscriber hereunder is several and not joint with the
obligations of any other subscribers for the purchase of Units in the Offering
(the “Other Subscribers”), and the Subscriber shall not be responsible in any
way for the performance of the obligations of any Other
Subscribers. Nothing contained herein or in any other agreement or
document delivered at the Subscription Closing, and no action taken by the
Subscriber pursuant hereto, shall be deemed to constitute the Subscriber and the
Other Subscribers as a partnership, an association, a joint venture or any other
kind of entity, or create a presumption that the Subscriber and the Other
Subscribers are in any way acting in concert with respect to such obligations or
the transactions contemplated by this Agreement. The Subscriber shall
be entitled to protect and enforce the Subscriber’s rights, including without
limitation the rights arising out of this Agreement, and it shall not be
necessary for any Other Subscriber to be joined as an additional party in any
proceeding for such purpose. The language used in this Agreement will
be deemed to be the language chosen by the parties to express their mutual
intent, and no rules of strict construction will be applied against any
party. The Subscriber is not acting as part of a “group” (as that
term is used in Section 13(d) of the 0000 Xxx) in negotiating and entering into
this Agreement or purchasing the Units or acquiring, disposing of or voting any
of the underlying Common Shares or the Warrant Shares. The Company
hereby confirms that it understands and agrees that the Subscriber is not acting
as part of any such group.
[SIGNATURE
PAGE FOLLOWS]
13
IN
WITNESS WHEREOF, the parties have executed this Agreement as of the day and year
first written above.
__________________________________ ____________________________________
Full
Legal Name of Subscriber (Please
print) Full
Legal Name of Co-Subscriber (if applicable)
__________________________________ ____________________________________
Signature
of (or on behalf of)
Subscriber Signature
of or on behalf of Co-Subscriber (if applicable)
Name:
Title:
__________________________________ ____________________________________
Address
of
Subscriber Address
of Co-Subscriber (if applicable)
__________________________________ ____________________________________
Social
Security or
Taxpayer
Social Security or Taxpayer Identification
Identification
Number of
Subscriber
Number of Co-Subscriber (if applicable)
__________________________________
Number of
Units Subscribed For
Subscription
Agreed to and Accepted
VeruTEK
Technologies, Inc., a Nevada corporation
|
By:
|
/s/ | |
Xxxx Xxxxxxx | |||
Chief Executive Officer | |||
14